Tuesday, 26 May 2020

Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment

The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.

from NDTV News - Special https://ift.tt/2M3KuBA
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Laser Power & Infra's Rs 742-Crore IPO To Open On July 9

Laser Power & Infra Ltd., an integrated manufacturer of power cables, conductors and specialised products for the power transmission and...